Reaffirming Previously Provided Outlook for Full-Year 2024, and adjusted EPS growth of at least 10% in 2025 Confirming it is not Pursuing a Combination with Humana Inc. Confirming Continuing to Use Capital to Drive Shareholder Value, including Share Repurchase and DividendsBLOOMFIELD, Conn., Nov. 11, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group ...